Regulators set to discuss likely link between mRNA Vaccines, heart inflammation

*The US Centers for Disease Control and Prevention’s Advisory Committee on Immunisation Practices is yet to determine if there is a causal relationship between the Coronavirus Vaccines and cases of myocarditis in certain consumers

Isola Moses | ConsumerConnect

Sequel to the reported number of cases of heart inflammation after the second dose of mRNA COVID-19 Vaccines in some consumers, the United States (US) Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunisation Practices is set to meet next week to discuss a potential link between heart inflammation and COVID-19 Vaccines that use messenger RNA (mRNA) technology.

ConsumerConnect gathered the regulator’s meeting was planned after vaccine safety monitoring systems indicated that a small portion of vaccinated people experienced a condition called myocarditis.

The CDC in a statement Thursday, June 10 said that the systems revealed a higher-than-expected number of cases of heart inflammation after the second dose of mRNA COVID-19 vaccines.

According to the American health regulatory agency, more than half of the cases occurred in patients between ages 12 and 24, who had received either Pfizer’s or Moderna’s vaccines.

It was learnt almost 80 percent of the case occurred in men, and most happened within a week of receiving the second shot of the Coronavirus vaccine.

In assessing the risk involved, report said not less than 81 percent of the 475 people who experienced the condition had a full recovery from their symptoms.

But those who experienced the condition accounted for less than 9 percent of doses administered overall.

Tom Shimabukuro, safety expert at CDC, said: “We’re still learning about the rates of myocarditis and pericarditis.

“As we gather more information, we’ll begin to get a better idea of the post-vaccination rates and hopefully be able to get more detailed information by age group.”

The agency’s Advisory Committee on Immunisation Practices will convene to examine the available evidence and assess the risk of myocarditis following mRNA vaccination for COVID-19, CDC said.

Pfizer said it supports the CDC’s assessment of the condition.

The agency further stated: “It is important to understand that a careful assessment of the reports is ongoing and it has not been concluded that the mRNA COVID-19 Vaccines cause myocarditis or pericarditis.”

Kindly Share This Story